Skip to main content
search

Regulatory

Sign up

Latest resources

Featured resource

Upcoming regulatory webinars

Latest regulatory blogs

Meet our experts at the following events

Conference

SCDM EMEA 2026

May 3 - 5, 2026 – Copenhagen, Denmark – Booth 12
Conference

EMWA Spring Conference 2026

May 5 - 8, 2026 – Barcelona, Spain
Conference

AMWA NorCal Pacific Coast Conference

May 15 - 16, 2026 – North Carolina Biotech Center. Durham, NC

All regulatory resources

ADC Dose Optimization: Applying Model-Informed Strategies in Development

ADC, Biologics, Clinical Pharmacology, Clinical Trials, Drug Development, Drug Safety, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Blog

FDA ESG Integration: Why Now Is the Time to Move Beyond Manual Submissions

Certara Products - GlobalSubmit, Blog

RAPS sponsored webinar: From Silos to Synergy: A Practical Guide to Integrating Regulatory Writing and Operations for Seamless Submissions

Certara Services, Webinar

Extending the Value of Antibody–Drug Conjugates: Model-Informed Labeling, Expansion, and Market Access

ADC, Certara Services, Clinical Pharmacology, Drug Development, Modeling and Simulation, On-Demand Webinar

AMWA NorCal Pacific Coast Conference

Certara Services, Conference

Earning Regulatory Trust: Practical Strategies to Increase Model Acceptance in MIDD

Certara Services, Drug Development, Webinar

CDISC SEND Updates Nonclinical Drug Developers Need to Know

Blog LP – popular, CDISC SEND, Certara Products, Certara Products - SEND Explorer, Data Standards, Regulatory - Blog, Blog

Final ICH M15 Guidance: Aligning MIDD with Global Regulatory Expectations

Certara Products, Certara Products - Phoenix, Certara Products - Simcyp, Certara Services, Clinical Pharmacology, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Webinar

Integrated Population Pharmacokinetic, Pharmacodynamic, and Safety Analyses to Inform Dosage Selection in the Clinical Development of the ATR Inhibitor Tuvusertib

Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Drug Safety, Model Informed Drug Development, Modeling and Simulation - PK/PD, Therapeutic Specialties, Publication

Pinnacle 21 Community or Enterprise: How to decide which is right for your study

Certara Products - Pinnacle 21, Clinical Trials, Data Standards, Webinar

Paediatric development of radiopharmaceutical imaging agents and radioligand therapeutics

Clinical Pharmacology, Drug Development, Drug Safety, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PK/PD, Therapeutic Specialties, Publication

Shaping the Future of Medical Writing: Key Themes for 2026

Certara Services, Blog
Sign up to newsletter

Why sign up? Because transforming drug development is not just our goal—it’s our obsession. If it’s yours too, then be the first to know of new insights and join us in pushing the boundaries of science.